ArticleAnnals of hematology2026

Real-world outcomes of ponatinib in heavily pretreated patients with chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia.

Seok Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.